Farms.com Home   News

U.S. swine industry creates coalition to combat H5N1 threat

The U.S. swine industry has proactively united to combat the potential threat of H5N1 influenza, a highly pathogenic avian influenza that has impacted poultry flocks and dairy herds, humans and a few pigs on an isolated Oregon hobby farm. Since March 2024, a dedicated working group, comprised of representatives from the American Association of Swine Veterinarians, National Pork Board, National Pork Producers Council and Swine Health Information Center, has been working continuously. Their mission: to prevent and prepare for a potential H5N1 outbreak response in commercial U.S. swine herds. 

Collaboration: Unified front against H5N1 
The emergence of H5N1 in dairy cattle in March 2024 was an eye-opening occurrence, prompting the immediate formation of the swine industry working group. Heather Fowler, director of producer and public health, NPB, emphasizes the need for multi-species, interdisciplinary collaboration to adequately prepare for and respond to an H5N1 outbreak. Marisa Rotolo, director of swine health, NPB, echoes this, highlighting how the outbreak has prompted livestock commodity groups to strengthen relationships and share knowledge across the barnyard. 

This unified approach ensures a more efficient and effective response. As Fowler states, “By collaborating we are not only sharing the load but also making sure the right people are involved in the conversation at the right time.” This synergy leverages the unique strengths and expertise of each organization, ultimately benefiting producers and veterinarians. AASV, for instance, has leveraged its committees, comprised of global experts in influenza viruses, to review and provide feedback on the draft response plan, ensuring it is as realistic and useful as possible. 

Click here to see more...

Trending Video

How Aurora Pharmaceutical Became a Leader in Animal Health

Video: How Aurora Pharmaceutical Became a Leader in Animal Health

Dr. Michael Strobel, Founder and CEO of Aurora Pharmaceutical, discusses the company's remarkable journey from a veterinarian-led startup to a leading developer and manufacturer of animal health solutions.

In this exclusive interview, Dr. Strobel shares how Aurora Pharmaceutical was built around a simple but powerful mission: putting customers, producers, veterinarians, pet owners, and patients first. Learn how the company has grown by focusing on high-quality, science-backed, and cost-effective solutions for livestock, companion animals, and human health markets.

Discover how Aurora's commitment to innovation, affordability, and customer service continues to drive its expansion across swine, cattle, poultry, equine, companion animal, and human health sectors. Dr. Strobel also discusses the importance of understanding real-world challenges facing producers and veterinarians and how Aurora develops practical solutions that improve animal health while supporting producer profitability. Aurora's veterinarian-founded approach, commitment to American manufacturing, and focus on delivering value have helped establish the company as a trusted partner throughout the animal health industry.